Prothrombin Fragment 1 + 2 Measures Treatment Effect in Patients with Antiphospholipid Syndrome - Prevalance, risk, and interaction

Author： Yamazaki M. Asakura H. Saito M. Jokaji H. Uotani C. Kumabashiri I. Morishita E. Aoshima K. Matsuda T. Triplett D.A.

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.91, Iss.3, 1998-08, pp. : 121-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PROTHROMBIN ACTIVATION FRAGMENT (F1.2) IS INCREASED IN PREGNANT PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES.

By Zangari M. Lockwood C.J. Scher J. Rand J.H.

Thrombosis Research, Vol. 85, Iss. 3, 1997-02 ,pp. : 177-183

Elsevier

Access to resources Recommend Favorite

Antiphospholipid syndrome: treatment controversies

By Ruiz-Irastorza Guillermo Khamashta Munther A

Future Rheumatology, Vol. 1, Iss. 3, 2006-06 ,pp. : 345-353

Future Medicine

Access to resources Recommend Favorite

Urinary prothrombin fragment 1+2 in patients with venous thrombosis and myocardial infarction

By Es J.

Journal of Thrombosis and Thrombolysis, Vol. 36, Iss. 1, 2013-07 ,pp. : 47-49

Springer Publishing Company

Access to resources Recommend Favorite

Antiphospholipid syndrome in children: review of pathogenesis, diagnosis and treatment

By MacDermott Emma J Lehman Thomas JA

Future Rheumatology, Vol. 2, Iss. 2, 2007-04 ,pp. : 203-211

Future Medicine

Access to resources Recommend Favorite

Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies

By Miesbach Wolfgang Scharrer Inge Asherson Ronald

Clinical Rheumatology, Vol. 25, Iss. 6, 2006-11 ,pp. : 840-844

Springer Publishing Company

Access to resources Recommend Favorite